AIDS News and Research

RSS

Experts available for comment on controversy over a nevirapine

The controversy over a nevirapine clinical trial conducted in the late 1990s threatens to limit the use of a drug that has saved hundreds of thousands of babies in the developing world from HIV infection, according to experts from the HIV Medicine Association (HIVMA) of the Infectious Diseases Society of America (IDSA).

7 Apr 2005

Integrating HIV prevention and care in Africa

On April 15, 2005 the UCLA AIDS Institute will host a full day symposium on AIDS in Africa entitled Integrating HIV Prevention and Care in Africa: Existing Challenges and Innovative Solutions.

6 Apr 2005

When treating malaria is a waste of money

Africa may fail to benefit from new and better drugs for malaria because of massive misdiagnosis of the disease by health workers and patients.

5 Apr 2005

International commitment to reduce maternal and child deaths by 2015 will not be met

An international commitment to reduce maternal and child deaths by 2015 will not be met at the current pace unless rapid and coordinated action is taken now, the World Health Organization (WHO) has warned.

5 Apr 2005

HIV/AIDS impacts on population dynamics and economic growth

Top officials at the United Nations Commission on Population and Development, at its yearly meeting are focussing on the negative effects of HIV/AIDS on population dynamics, including population losses and decreased life expectancy, as well as the pandemic's links to increased extreme poverty, stalled economic growth and poor reproductive health in many parts of the world.

5 Apr 2005

Discrimination against AIDS patients to be stopped in India

India's Health Minister Anbumani Ramadoss has told an AIDS conference that his government plans to introduce a law to stop discrimination against people infected with the deadly virus.

4 Apr 2005

Rabies, HIV, cancer and malaria could all be prevented with pills in the future

Rabies, HIV, cancer and malaria could all be prevented with pills in the future, if a new technique using specially modified viruses to deliver vaccines is adopted, according to scientists speaking today (Tuesday, 05 April 2005) at the Society for General Microbiology's 156th Meeting at Heriot-Watt University, Edinburgh.

4 Apr 2005

Glaxo's CEO must answer questions in AIDS drug patent piracy case

A California federal court has ruled that GlaxoSmithKline's (GSK) Chief Executive Officer, Jean-Pierre Garnier, must answer further questions in a deposition in a patent piracy lawsuit brought against the British drug giant over GSK's patent for AZT (Retrovir), the first AIDS drug.

4 Apr 2005

Oral sex not sex say teens

Many teenagers in the US do not regard oral sex as sex and one in five say they have experience of it.

4 Apr 2005

New chemicals to inhibit HIV infection

In corporation with peers from the Mount Sinai School of Medicine, New York University, researchers from the University of Science and Technology of China (USTC), a CAS affiliate, have come up with new chemical inhibitors against HIV reproduction, marking a significant progress in the development of anti-AIDS drugs based on natural host resistance.

4 Apr 2005

Cannabis-based medicines given in a highly-controlled clinical environment unexpectedly lead to strong psychotic effects

Volunteers taking cannabis-based therapeutic drugs as part of a controlled trial, which had been approved by an ethics board as safe for the subjects, experienced psychotic effects just as strong as if they had smoked cannabis. These findings, highly unexpected in such a controlled environment, are published today in the peer-reviewed, Open Access journal BMC Psychiatry.

3 Apr 2005

New drug approved for treating endometriosis

Drug manufacturer Pfizer announced today that the U.S. Food and Drug Administration (FDA) has given approval for the release of depo-subQ provera 104 to be prescribed for the management of pain associated with endometriosis, a gynecological condition that affects one in ten women of reproductive age.

30 Mar 2005

AIDS threatens Russian social and economic security

At a meeting this week on the fight with AIDS, Russian Vice-Premier Alexander Zhukov said the AIDS epidemic threatens Russian social and economic security and the spread of the disease is no longer just a medical problem.

30 Mar 2005

Primary health care providers should incorporate HIV testing into routine patient care for all sexually active individuals

Primary health care providers should incorporate human immunodeficiency virus (HIV) testing into routine patient care for all sexually active individuals, regardless of risk factors, say a group of physician/researchers at Emory University School of Medicine, Brown Medical School, and the Johns Hopkins School of Medicine.

30 Mar 2005

New drug to treat chronic hepatitis B

The U.S. Food and Drug Administration (FDA) has given approval for a new drug to treat the potentially life-threatening disease Chronic hepatitis B.

30 Mar 2005

HIV patients who delay seeking care are much sicker when they begin care

Patients recently diagnosed with human immunodeficiency virus (HIV) are significantly more likely to seek medical treatment if they are followed even briefly by a case manager, according to findings of the national Antiretroviral Treatment Access Study (ARTAS).

30 Mar 2005

Medication that both stimulates appetite and reduces metabolic rate

Scientists at Oregon Health & Science University, in collaboration with Neurocrine Biosciences Inc., have successfully tested a research medication that both stimulates appetite and reduces metabolic rate in preclinical trials.

30 Mar 2005

AIDS virus initially more destructive than first thought

The AIDS virus destroys more than half of the immune cells that might recognize and help fight it, within days of infection according to US researchers, and this revelation might necessitate a re-evaluation of how the deadly infection should be tackled.

28 Mar 2005

Vaccine prevents deadly pneumonia in African children

Global health leaders today presented new research showing that vaccinating infants against Streptococcus pneumoniae -- a bacterium that causes deadly pneumonia, meningitis and sepsis -- could substantially reduce death and serious illness among children in the developing world. If used widely, a pneumococcal conjugate vaccine could prevent hundreds of thousands of child deaths each year.

28 Mar 2005

New therapy for treating cat allergies looks promising

Andrew Saxon, M.D., and a team of researchers at University of California, Los Angeles (UCLA) have found that a molecule designed to block cat allergies can prevent allergic reactions in laboratory mice and was also successful when tested on human cells in a test tube.

28 Mar 2005